{
    "abstract": "Background In the elderly, traditional influenza inactivated vaccines are often only modestly immunogenic, owing to immunosenescence. Given that adjuvantation is a means of enhancing the immune response, the trivalent inactivated vaccine adjuvanted with MF59 (MF59-TIV) was specifically designed to overcome this problem. Considering that, for ethical reasons, the absolute effectiveness of an influenza vaccine in the elderly cannot be demonstrated in placebo-controlled studies, the present study aimed to assess the effectiveness of MF59-TIV in preventing influenza-related outcomes in the elderly. Methods We conducted a systematic review of observational studies aimed at evaluating the effectiveness of MF59-TIV against influenza-related outcomes. Results of single studies were pooled whenever possible. Results Of the 1993 papers screened, 11 (6 case-control, 3 cohort and 2 prospective case-control) studies were identified. Hospitalization due to pneumonia/influenza and laboratory-confirmed influenza were reported in more than one study, while other outcomes (influenza-like illness, cardio- and cerebrovascular accidents) were investigated only by one study each. Pooled analysis of four case-control studies showed an adjusted MF59-TIV effectiveness of 51% (95% CI: 39\u201361%) against hospitalizations for pneumonia/influenza among community-dwelling seniors. Pooled results of the adjusted vaccine effectiveness against laboratory-confirmed influenza were also high (60.1%), although the 95% CI passed through zero (\u22121.3 to 84.3%). Other single community-based studies showed very high effectiveness of MF59-TIV in preventing hospitalizations for acute coronary [87% (95% CI: 35\u201397%)] and cerebrovascular [93% (95% CI: 52\u201399%)] events. MF59-TIV proved highly effective [94% (95% CI: 47\u2013100%] in reducing influenza-like illness among institutionalized elderly. Furthermore, MF59-TIV displayed greater efficacy than non-adjuvanted vaccines in preventing hospitalizations due to pneumonia/influenza [adjusted risk ratio 0.75 (95% CI: 0.57\u20130.98)] and laboratory-confirmed influenza [adjusted odds ratio 0.37 (0.14\u20130.96)]. Conclusions Our results suggest that MF59-TIV is effective in reducing several influenza-related outcomes among the elderly, especially hospitalizations due to influenza-related complications.",
    "author_highlights": [
        {
            "endOffset": 14451,
            "sentence": "Traditional inactivated flu vaccines are often poorly immunogenic in the elderly.",
            "startOffset": 14370
        },
        {
            "endOffset": 14525,
            "sentence": "Adjuvantation with MF59 may increase vaccine effectiveness among seniors.",
            "startOffset": 14452
        },
        {
            "endOffset": 14616,
            "sentence": "The aim was to assess MF59-vaccine effectiveness in preventing influenza-related outcomes.",
            "startOffset": 14526
        },
        {
            "endOffset": 14701,
            "sentence": "Our review suggests that MF59-adjuvanted vaccine is highly effective in the elderly.",
            "startOffset": 14617
        },
        {
            "endOffset": 14786,
            "sentence": "Field effectiveness of MF59-adjuvanted vaccine is superior to unadjuvanted vaccines.",
            "startOffset": 14702
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Lone",
                    "initial": "L.",
                    "last": "Simonsen"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Taylor"
                },
                {
                    "first": "Cecile",
                    "initial": "C.",
                    "last": "Viboud"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Miller"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Jackson"
                }
            ],
            "doi": "10.1016/S1473-3099(07)70236-0",
            "firstpage": "658",
            "issn": "14733099",
            "lastpage": "666",
            "pmid": "17897608",
            "pub_year": 2007,
            "title": "Mortality benefits of influenza vaccination in elderly people: an ongoing controversy",
            "volume": "7"
        },
        "b0010": {
            "authors": [],
            "firstpage": "461",
            "issn": "00498114",
            "lastpage": "476",
            "pmid": "23210147",
            "pub_year": 2012,
            "title": "Vaccines against influenza WHO position paper - November 2012.",
            "volume": "87"
        },
        "b0015": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Gasparini"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Lucioni"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Lai"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Maggioni"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Sticchi"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Durando"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Morelli"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Comino"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Calderisi"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Crovari"
                }
            ],
            "doi": "10.1016/S0264-410X(02)00507-8",
            "firstpage": "B50",
            "issn": "0264410X",
            "lastpage": "B54",
            "pmid": "12477420",
            "pub_year": 2002,
            "title": "Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria",
            "volume": "20"
        },
        "b0020": null,
        "b0025": {
            "authors": [
                {
                    "first": "Hans C.",
                    "initial": "H.C.",
                    "last": "R\u00fcmke"
                },
                {
                    "first": "Jan Hendrik",
                    "initial": "J.H.",
                    "last": "Richardus"
                },
                {
                    "first": "Lars",
                    "initial": "L.",
                    "last": "Rombo"
                },
                {
                    "first": "Karlis",
                    "initial": "K.",
                    "last": "Pauksens"
                },
                {
                    "first": "Georg",
                    "initial": "G.",
                    "last": "Pla\u00dfmann"
                },
                {
                    "first": "Christelle",
                    "initial": "C.",
                    "last": "Durand"
                },
                {
                    "first": "Jeanne Marie",
                    "initial": "J.M.",
                    "last": "Devaster"
                },
                {
                    "first": "Walth\u00e8re",
                    "initial": "W.",
                    "last": "Dew\u00e9"
                },
                {
                    "first": "Lidia",
                    "initial": "L.",
                    "last": "Oostvogels"
                }
            ],
            "doi": "10.1186/1471-2334-13-348",
            "issn": "14712334",
            "pub_year": 2013,
            "title": "Selection of an adjuvant for seasonal influenza vaccine in elderly people: Modelling immunogenicity from a randomized trial",
            "volume": "13"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Derek T.",
                    "initial": "D.T.",
                    "last": "O'Hagan"
                },
                {
                    "first": "Theodore",
                    "initial": "T.",
                    "last": "Tsai"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1007/978-3-0346-0279-2_14",
            "firstpage": "327",
            "lastpage": "357",
            "pub_year": 2011,
            "title": "Emulsion-based adjuvants for improved influenza vaccines"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Angelika",
                    "initial": "A.",
                    "last": "Banzhoff"
                },
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Pellegrini"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Fragapane"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Groth"
                },
                {
                    "first": "Audino",
                    "initial": "A.",
                    "last": "Podda"
                }
            ],
            "doi": "10.1111/j.1750-2659.2008.00059.x",
            "firstpage": "243",
            "issn": "17502640",
            "lastpage": "249",
            "pmid": "19453401",
            "pub_year": 2008,
            "title": "MF59\u00ae -adjuvanted vaccines for seasonal and pandemic influenza prophylaxis",
            "volume": "2"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Theodore F.",
                    "initial": "T.F.",
                    "last": "Tsai"
                }
            ],
            "doi": "10.3947/ic.2013.45.2.159",
            "firstpage": "159",
            "issn": "20932340",
            "lastpage": "174",
            "pub_year": 2013,
            "title": "Fluad\u00ae-mf59\u00ae-adjuvanted influenza vaccine in older adults",
            "volume": "45"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Audino",
                    "initial": "A.",
                    "last": "Podda"
                }
            ],
            "doi": "10.1016/S0264-410X(00)00499-0",
            "firstpage": "2673",
            "issn": "0264410X",
            "lastpage": "2680",
            "pmid": "11257408",
            "pub_year": 2001,
            "title": "The adjuvanted influenza vaccines with novel adjuvants: Experience with the MF59-adjuvanted vaccine",
            "volume": "19"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Michele",
                    "initial": "M.",
                    "last": "Pellegrini"
                },
                {
                    "first": "Uwe",
                    "initial": "U.",
                    "last": "Nicolay"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Lindert"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Groth"
                },
                {
                    "first": "Giovanni",
                    "initial": "G.",
                    "last": "Della Cioppa"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.08.101",
            "firstpage": "6959",
            "issn": "0264410X",
            "lastpage": "6965",
            "pmid": "19751689",
            "pub_year": 2009,
            "title": "MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database",
            "volume": "27"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Camilloni"
                },
                {
                    "first": "Michela",
                    "initial": "M.",
                    "last": "Basileo"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Valente"
                },
                {
                    "first": "Emilia",
                    "initial": "E.",
                    "last": "Nunzi"
                },
                {
                    "first": "Anna Maria",
                    "initial": "A.M.",
                    "last": "Iorio"
                }
            ],
            "doi": "10.1080/21645515.2015.1011562",
            "firstpage": "553",
            "issn": "21645515",
            "lastpage": "563",
            "pmid": "25714138",
            "pub_year": 2015,
            "title": "Immunogenicity of intramuscular MF59- Adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review",
            "volume": "11"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Geoffrey A.",
                    "initial": "G.A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Szilagyi"
                }
            ],
            "doi": "10.1086/652404",
            "firstpage": "1607",
            "issn": "00221899",
            "lastpage": "1610",
            "pmid": "20402594",
            "pub_year": 2010,
            "title": "Vaccine epidemiology: Efficacy, effectiveness, and the translational research roadmap",
            "volume": "201"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Donna F.",
                    "initial": "D.F.",
                    "last": "Stroup"
                },
                {
                    "first": "Jesse A.",
                    "initial": "J.A.",
                    "last": "Berlin"
                },
                {
                    "first": "Sally C.",
                    "initial": "S.C.",
                    "last": "Morton"
                },
                {
                    "first": "Ingram",
                    "initial": "I.",
                    "last": "Olkin"
                },
                {
                    "first": "G. David",
                    "initial": "G.D.",
                    "last": "Williamson"
                },
                {
                    "first": "Drummond",
                    "initial": "D.",
                    "last": "Rennie"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Moher"
                },
                {
                    "first": "Betsy J.",
                    "initial": "B.J.",
                    "last": "Becker"
                },
                {
                    "first": "Theresa Ann",
                    "initial": "T.A.",
                    "last": "Sipe"
                },
                {
                    "first": "Stephen B.",
                    "initial": "S.B.",
                    "last": "Thacker"
                }
            ],
            "doi": "10.1001/jama.283.15.2008",
            "firstpage": "2008",
            "issn": "00987484",
            "lastpage": "2012",
            "pmid": "10789670",
            "pub_year": 2000,
            "title": "Meta-analysis of observational studies in epidemiology: A proposal for reporting",
            "volume": "283"
        },
        "b0070": null,
        "b0075": {
            "authors": [
                {
                    "first": "Michael T.",
                    "initial": "M.T.",
                    "last": "Osterholm"
                },
                {
                    "first": "Nicholas S.",
                    "initial": "N.S.",
                    "last": "Kelley"
                },
                {
                    "first": "Alfred",
                    "initial": "A.",
                    "last": "Sommer"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                }
            ],
            "doi": "10.1016/S1473-3099(11)70295-X",
            "firstpage": "36",
            "issn": "14733099",
            "lastpage": "44",
            "pmid": "22032844",
            "pub_year": 2012,
            "title": "Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis",
            "volume": "12"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Trang",
                    "initial": "T.",
                    "last": "Vu"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Farish"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Jenkins"
                },
                {
                    "first": "Heath",
                    "initial": "H.",
                    "last": "Kelly"
                }
            ],
            "doi": "10.1016/S0264-410X(02)00041-5",
            "firstpage": "1831",
            "issn": "0264410X",
            "lastpage": "1836",
            "pmid": "11906772",
            "pub_year": 2002,
            "title": "A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community",
            "volume": "20"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Jefferson"
                },
                {
                    "first": "Carlo",
                    "initial": "C.",
                    "last": "Di Pietrantonj"
                },
                {
                    "first": "Lubna A.",
                    "initial": "L.A.",
                    "last": "Al-Ansary"
                },
                {
                    "first": "Eliana",
                    "initial": "E.",
                    "last": "Ferroni"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Thorning"
                },
                {
                    "first": "Roger E.",
                    "initial": "R.E.",
                    "last": "Thomas"
                }
            ],
            "firstpage": "CD004876",
            "issn": "1469493X",
            "pmid": "20166072",
            "pub_year": 2010,
            "title": "Vaccines for preventing influenza in the elderly.",
            "volume": "2"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Sharon E.",
                    "initial": "S.E.",
                    "last": "Frey"
                },
                {
                    "first": "Mari Rose Aplasca De Los",
                    "initial": "M.R.A.D.L.",
                    "last": "Reyes"
                },
                {
                    "first": "Humberto",
                    "initial": "H.",
                    "last": "Reynales"
                },
                {
                    "first": "Nancy Nazaire",
                    "initial": "N.N.",
                    "last": "Bermal"
                },
                {
                    "first": "Uwe",
                    "initial": "U.",
                    "last": "Nicolay"
                },
                {
                    "first": "Vas",
                    "initial": "V.",
                    "last": "Narasimhan"
                },
                {
                    "first": "Eduardo",
                    "initial": "E.",
                    "last": "Forleo-Neto"
                },
                {
                    "first": "Ashwani Kumar",
                    "initial": "A.K.",
                    "last": "Arora"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.07.013",
            "firstpage": "5027",
            "issn": "0264410X",
            "lastpage": "5034",
            "pmid": "25045825",
            "pub_year": 2014,
            "title": "Comparison of the safety and immunogenicity of an MF59\u00ae-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects",
            "volume": "32"
        },
        "b0095": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Minutello"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Senatore"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Cecchinelli"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Bianchi"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Andreani"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Podda"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Crovari"
                }
            ],
            "doi": "10.1016/S0264-410X(98)00185-6",
            "firstpage": "99",
            "issn": "0264410X",
            "lastpage": "104",
            "pmid": "9987141",
            "pub_year": 1999,
            "title": "Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons",
            "volume": "17"
        },
        "b0100": null,
        "b0105": null,
        "b0110": {
            "authors": [
                {
                    "first": "Charles R.",
                    "initial": "C.R.",
                    "last": "Beck"
                },
                {
                    "first": "Bruce C.",
                    "initial": "B.C.",
                    "last": "McKenzie"
                },
                {
                    "first": "Ahmed B.",
                    "initial": "A.B.",
                    "last": "Hashim"
                },
                {
                    "first": "Rebecca C.",
                    "initial": "R.C.",
                    "last": "Harris"
                },
                {
                    "first": "Arina",
                    "initial": "A.",
                    "last": "Zanuzdana"
                },
                {
                    "first": "Gabriel",
                    "initial": "G.",
                    "last": "Agboado"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Orton"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "B\u00e9chard-Evans"
                },
                {
                    "first": "Gemma",
                    "initial": "G.",
                    "last": "Morgan"
                },
                {
                    "first": "Charlotte",
                    "initial": "C.",
                    "last": "Stevenson"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Weston"
                },
                {
                    "first": "Mitsuru",
                    "initial": "M.",
                    "last": "Mukaigawara"
                },
                {
                    "first": "Joanne",
                    "initial": "J.",
                    "last": "Enstone"
                },
                {
                    "first": "Glenda",
                    "initial": "G.",
                    "last": "Augustine"
                },
                {
                    "first": "Mobasher",
                    "initial": "M.",
                    "last": "Butt"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Kim"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Puleston"
                },
                {
                    "first": "Girija",
                    "initial": "G.",
                    "last": "Dabke"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Howard"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "O'Boyle"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "O'Brien"
                },
                {
                    "first": "Lauren",
                    "initial": "L.",
                    "last": "Ahyow"
                },
                {
                    "first": "Helene",
                    "initial": "H.",
                    "last": "Denness"
                },
                {
                    "first": "Siobhan",
                    "initial": "S.",
                    "last": "Farmer"
                },
                {
                    "first": "Jose",
                    "initial": "J.",
                    "last": "Figureroa"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Fisher"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Greaves"
                },
                {
                    "first": "Munib",
                    "initial": "M.",
                    "last": "Haroon"
                },
                {
                    "first": "Sophie",
                    "initial": "S.",
                    "last": "Haroon"
                },
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Hird"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Isba"
                },
                {
                    "first": "David A.",
                    "initial": "D.A.",
                    "last": "Ishola"
                },
                {
                    "first": "Marko",
                    "initial": "M.",
                    "last": "Kerac"
                },
                {
                    "first": "Vivienne",
                    "initial": "V.",
                    "last": "Parish"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Roberts"
                },
                {
                    "first": "Julia",
                    "initial": "J.",
                    "last": "Rosser"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Theaker"
                },
                {
                    "first": "Dean",
                    "initial": "D.",
                    "last": "Wallace"
                },
                {
                    "first": "Neil",
                    "initial": "N.",
                    "last": "Wigglesworth"
                },
                {
                    "first": "Liz",
                    "initial": "L.",
                    "last": "Lingard"
                },
                {
                    "first": "Yana",
                    "initial": "Y.",
                    "last": "Vinogradova"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Horiuchi"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Pe\u00f1alver"
                },
                {
                    "first": "Jonathan S.",
                    "initial": "J.S.",
                    "last": "Nguyen-Van-Tam"
                }
            ],
            "doi": "10.1371/journal.pone.0029249",
            "issn": "19326203",
            "pmid": "22216224",
            "pub_year": 2011,
            "title": "Influenza vaccination for immunocompromised patients: Systematic review and meta-analysis from a public health policy perspective",
            "volume": "6"
        },
        "b0115": null,
        "b0120": {
            "authors": [
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Santiago",
                    "initial": "S.",
                    "last": "P\u00e9rez Hoyos"
                },
                {
                    "first": "\u00c1ngel",
                    "initial": "A.",
                    "last": "Belenguer Varea"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Gonz\u00e1lez Vidal"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.07.017",
            "firstpage": "283",
            "issn": "0264410X",
            "lastpage": "289",
            "pmid": "15530669",
            "pub_year": 2004,
            "title": "Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age",
            "volume": "23"
        },
        "b0125": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Iob"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Brianti"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Zamparo"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Gallo"
                }
            ],
            "doi": "10.1017/S0950268805003936",
            "firstpage": "687",
            "issn": "09502688",
            "lastpage": "693",
            "pmid": "16050515",
            "pub_year": 2005,
            "title": "Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy",
            "volume": "133"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                },
                {
                    "first": "\u00c1ngel Belenguer",
                    "initial": "A.B.",
                    "last": "Varea"
                },
                {
                    "first": "Germ\u00e1n Schwarz",
                    "initial": "G.S.",
                    "last": "Chavarri"
                },
                {
                    "first": "Jos\u00e9 A.Lluch",
                    "initial": "J.A.L.",
                    "last": "Rodrigo"
                },
                {
                    "first": "Santiago P\u00e9rez",
                    "initial": "S.P.",
                    "last": "Hoyos"
                },
                {
                    "first": "David Gonz\u00e1lez",
                    "initial": "D.G.",
                    "last": "Vidal"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.08.039",
            "firstpage": "7313",
            "issn": "0264410X",
            "lastpage": "7321",
            "pmid": "17889411",
            "pub_year": 2007,
            "title": "Effectiveness of MF59\u2122-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly",
            "volume": "25"
        },
        "b0135": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Arnedo-Pena"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Ruiz-Garc\u00eda"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "P\u00e9rez-Vilar"
                },
                {
                    "first": "J. L.",
                    "initial": "J.L.",
                    "last": "Mic\u00f3-Esparza"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Belenguer-Varea"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Carratal\u00e1-Munuera"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Gil-Guill\u00e9n"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Schwarz-Chavarri"
                }
            ],
            "doi": "10.1016/j.vaccine.2012.07.006",
            "firstpage": "5714",
            "issn": "0264410X",
            "lastpage": "5720",
            "pmid": "22819720",
            "pub_year": 2012,
            "title": "Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case-case comparison, case-control study",
            "volume": "30"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Salvatore",
                    "initial": "S.",
                    "last": "Mannino"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Villa"
                },
                {
                    "first": "Giovanni",
                    "initial": "G.",
                    "last": "Apolone"
                },
                {
                    "first": "Noel S.",
                    "initial": "N.S.",
                    "last": "Weiss"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Groth"
                },
                {
                    "first": "Ivana",
                    "initial": "I.",
                    "last": "Aquino"
                },
                {
                    "first": "Liana",
                    "initial": "L.",
                    "last": "Boldori"
                },
                {
                    "first": "Fausta",
                    "initial": "F.",
                    "last": "Caramaschi"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Gattinoni"
                },
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Malchiodi"
                },
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Rothman"
                }
            ],
            "doi": "10.1093/aje/kws313",
            "firstpage": "527",
            "issn": "14766256",
            "lastpage": "533",
            "pmid": "22940713",
            "pub_year": 2012,
            "title": "Effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy.",
            "volume": "176"
        },
        "b0145": {
            "authors": [
                {
                    "first": "P. G.",
                    "initial": "P.G.",
                    "last": "Van Buynder"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Konrad"
                },
                {
                    "first": "J. L.",
                    "initial": "J.L.",
                    "last": "Van Buynder"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Brodkin"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Krajden"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Ramler"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Bigham"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.07.059",
            "firstpage": "6122",
            "issn": "0264410X",
            "lastpage": "6128",
            "pmid": "23933368",
            "pub_year": 2013,
            "title": "The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly",
            "volume": "31"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Roberto",
                    "initial": "R.",
                    "last": "Gasparini"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Amicizia"
                },
                {
                    "first": "Piero Luigi",
                    "initial": "P.L.",
                    "last": "Lai"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Rossi"
                },
                {
                    "first": "Donatella",
                    "initial": "D.",
                    "last": "Panatto"
                }
            ],
            "doi": "10.4161/hv.22231",
            "firstpage": "144",
            "issn": "21645515",
            "lastpage": "152",
            "pmid": "23143775",
            "pub_year": 2013,
            "title": "Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V\u00ae and Fluad\u00ae) in preventing hospitalization for influenza and pneumonia in the elderly: A matched case-control study",
            "volume": "9"
        },
        "b0155": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Natividad-Sancho"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Calabuig-P\u00e9rez"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Lluch-Rodrigo"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Pastor-Villalba"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Mart\u00ednez-\u00dabeda"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "P\u00e9rez-Vilar"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.05.070",
            "firstpage": "3995",
            "issn": "0264410X",
            "lastpage": "4002",
            "pmid": "23731629",
            "pub_year": 2013,
            "title": "MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system",
            "volume": "31"
        },
        "b0160": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Spadea"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Unim"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Colamesta"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Meneghini"
                },
                {
                    "first": "A. M.",
                    "initial": "A.M.",
                    "last": "D'Amici"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Giudiceandrea"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "La Torre"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.07.077",
            "firstpage": "5290",
            "issn": "0264410X",
            "lastpage": "5294",
            "pmid": "25087677",
            "pub_year": 2014,
            "title": "Is the adjuvanted influenza vaccine more effective than the trivalent inactivated vaccine in the elderly population? Results of a case-control study",
            "volume": "32"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Lamberto",
                    "initial": "L.",
                    "last": "Manzoli"
                },
                {
                    "first": "John P.A.",
                    "initial": "J.P.A.",
                    "last": "Ioannidis"
                },
                {
                    "first": "Maria Elena",
                    "initial": "M.E.",
                    "last": "Flacco"
                },
                {
                    "first": "Corrado",
                    "initial": "C.",
                    "last": "De Vito"
                },
                {
                    "first": "Paolo",
                    "initial": "P.",
                    "last": "Villari"
                }
            ],
            "doi": "10.4161/hv.19917",
            "firstpage": "851",
            "issn": "2164554X",
            "lastpage": "862",
            "pmid": "22777099",
            "pub_year": 2012,
            "title": "Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses",
            "volume": "8"
        },
        "b0170": {
            "authors": [
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Gross"
                },
                {
                    "first": "A. W.",
                    "initial": "A.W.",
                    "last": "Hermogenes"
                },
                {
                    "first": "H. S.",
                    "initial": "H.S.",
                    "last": "Sacks"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Lau"
                },
                {
                    "first": "R. A.",
                    "initial": "R.A.",
                    "last": "Levandowski"
                }
            ],
            "doi": "10.7326/0003-4819-123-7-199510010-00008",
            "firstpage": "518",
            "issn": "00034819",
            "lastpage": "527",
            "pmid": "7661497",
            "pub_year": 1995,
            "title": "The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature",
            "volume": "123"
        },
        "b0175": {
            "authors": [
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Jefferson"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Rivetti"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Rivetti"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Rudin"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Di Pietrantonj"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Demicheli"
                }
            ],
            "doi": "10.1016/S0140-6736(05)67339-4",
            "firstpage": "1165",
            "issn": "01406736",
            "lastpage": "1174",
            "pmid": "16198765",
            "pub_year": 2005,
            "title": "Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review",
            "volume": "366"
        },
        "b0180": {
            "authors": [
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Baxter"
                }
            ],
            "doi": "10.1080/21645515.2015.1091130",
            "firstpage": "2712",
            "issn": "21645515",
            "lastpage": "2717",
            "pmid": "27435025",
            "pub_year": 2016,
            "title": "Evaluating the case for trivalent or quadrivalent influenza vaccines",
            "volume": "12"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Aye M.",
                    "initial": "A.M.",
                    "last": "Moa"
                },
                {
                    "first": "Abrar A.",
                    "initial": "A.A.",
                    "last": "Chughtai"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Muscatello"
                },
                {
                    "first": "Robin M.",
                    "initial": "R.M.",
                    "last": "Turner"
                },
                {
                    "first": "C. Raina",
                    "initial": "C.R.",
                    "last": "MacIntyre"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.06.064",
            "firstpage": "4092",
            "issn": "0264410X",
            "lastpage": "4102",
            "pmid": "27381642",
            "pub_year": 2016,
            "title": "Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials",
            "volume": "34"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Christopher S.",
                    "initial": "C.S.",
                    "last": "Ambrose"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                }
            ],
            "doi": "10.4161/hv.8.1.17623",
            "firstpage": "81",
            "issn": "2164554X",
            "lastpage": "88",
            "pub_year": 2012,
            "title": "The rationale for quadrivalent influenza vaccines",
            "volume": "8"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Carrie",
                    "initial": "C.",
                    "last": "Reed"
                },
                {
                    "first": "Martin I.",
                    "initial": "M.I.",
                    "last": "Meltzer"
                },
                {
                    "first": "Lyn",
                    "initial": "L.",
                    "last": "Finelli"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Fiore"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.12.098",
            "firstpage": "1993",
            "issn": "0264410X",
            "lastpage": "1998",
            "pmid": "22226861",
            "pub_year": 2012,
            "title": "Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine",
            "volume": "30"
        },
        "b0200": null,
        "b0205": {
            "authors": [
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "Landis"
                },
                {
                    "first": "G. G.",
                    "initial": "G.G.",
                    "last": "Koch"
                }
            ],
            "doi": "10.2307/2529310",
            "firstpage": "159",
            "issn": "0006341X",
            "lastpage": "174",
            "pmid": "843571",
            "pub_year": 1977,
            "title": "The measurement of observer agreement for categorical data",
            "volume": "33"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Hartling"
                },
                {
                    "first": "Andrea",
                    "initial": "A.",
                    "last": "Milne"
                },
                {
                    "first": "Michele P.",
                    "initial": "M.P.",
                    "last": "Hamm"
                },
                {
                    "first": "Ben",
                    "initial": "B.",
                    "last": "Vandermeer"
                },
                {
                    "first": "Mohammed",
                    "initial": "M.",
                    "last": "Ansari"
                },
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Tsertsvadze"
                },
                {
                    "first": "Donna M.",
                    "initial": "D.M.",
                    "last": "Dryden"
                }
            ],
            "doi": "10.1016/j.jclinepi.2013.03.003",
            "firstpage": "982",
            "issn": "08954356",
            "lastpage": "993",
            "pmid": "23683848",
            "pub_year": 2013,
            "title": "Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers",
            "volume": "66"
        },
        "b0215": {
            "authors": [
                {
                    "first": "Carson Ka Lok",
                    "initial": "C.K.L.",
                    "last": "Lo"
                },
                {
                    "first": "Dominik",
                    "initial": "D.",
                    "last": "Mertz"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Loeb"
                }
            ],
            "doi": "10.1186/1471-2288-14-45",
            "issn": "14712288",
            "pmid": "24690082",
            "pub_year": 2014,
            "title": "Newcastle-Ottawa Scale: Comparing reviewers' to authors' assessments",
            "volume": "14"
        },
        "b0220": {
            "authors": [
                {
                    "first": "Tuen Ching",
                    "initial": "T.C.",
                    "last": "Chan"
                },
                {
                    "first": "Ivan",
                    "initial": "I.",
                    "last": "Fan-Ngai Hung"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Ka-Hay Luk"
                },
                {
                    "first": "Leung Wing",
                    "initial": "L.W.",
                    "last": "Chu"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Hon-Wai Chan"
                }
            ],
            "doi": "10.1016/j.jamda.2013.10.008",
            "firstpage": "226",
            "issn": "15258610",
            "lastpage": "226.e6",
            "pmid": "24321878",
            "pub_year": 2014,
            "title": "Effectiveness of Influenza Vaccination in Institutionalized Older Adults: A Systematic Review",
            "volume": "15"
        }
    },
    "body_text": [
        {
            "endOffset": 17848,
            "parents": [],
            "secId": "s0005",
            "sentence": "Adjuvantation is a well-known means of increasing vaccine potency.",
            "startOffset": 17782,
            "title": "Introduction"
        },
        {
            "endOffset": 22043,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "No language restrictions were applied.",
            "startOffset": 22005,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 33415,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 33289,
                    "startOffset": 33285
                }
            },
            "secId": "s0060",
            "sentence": "The only study [25] that assessed MF59-TIV among institutionalized elderly subjects and had the outcome of ILI established a very high VE of 94%.",
            "startOffset": 33270,
            "title": "Discussion"
        },
        {
            "endOffset": 20515,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 20500,
                    "startOffset": 20496
                }
            },
            "secId": "s0015",
            "sentence": "As a guideline for reporting, the MOOSE (meta-analysis of observational studies in epidemiology) checklist [13] was consulted.",
            "startOffset": 20389,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 33595,
            "parents": [],
            "secId": "s0060",
            "sentence": "It is worth comparing our results with those obtained from previously published systematic reviews and meta-analyses.",
            "startOffset": 33478,
            "title": "Discussion"
        },
        {
            "endOffset": 23761,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "However, if the majority (\u2a7e90%) of study participants belonged to a group of interest, the study was included.",
            "startOffset": 23651,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 32817,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, the data support consistency of the estimates, since the 95% CIs of the meta-analyzed studies overlapped.",
            "startOffset": 32703,
            "title": "Discussion"
        },
        {
            "endOffset": 22691,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Subsequently, full texts of potentially eligible studies were assessed by applying a set of inclusion and exclusion criteria.",
            "startOffset": 22566,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 26464,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 26463,
                    "startOffset": 26459
                }
            },
            "secId": "s0035",
            "sentence": "All analyses were performed in MetaXL 5.0 [23].",
            "startOffset": 26417,
            "title": "Data analysis"
        },
        {
            "endOffset": 26832,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The vaccine manufacturer agreed with the list of studies included.",
            "startOffset": 26766,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 26765,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0125": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0130": {
                    "endOffset": 26692,
                    "startOffset": 26688
                },
                "b0135": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0140": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0145": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0150": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0155": {
                    "endOffset": 26676,
                    "startOffset": 26669
                },
                "b0160": {
                    "endOffset": 26676,
                    "startOffset": 26669
                }
            },
            "secId": "s0045",
            "sentence": "Of the 1993 records screened, 9 papers (8 [24\u201326,28\u201332] and 1 [27] retrieved through automatic and manual searches, respectively), corresponding to 11 studies [24\u201332] (one paper [26] reported results of three studies), met the inclusion criteria (Fig. 1).",
            "startOffset": 26510,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 25848,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "If the observed heterogeneity was low, i.e. with an I2 < 40%, a fixed-effects model using the inverse variance method for weighting was re-applied.",
            "startOffset": 25701,
            "title": "Data analysis"
        },
        {
            "endOffset": 30700,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 30699,
                    "startOffset": 30695
                }
            },
            "secId": "s0050",
            "sentence": "With regard to long-term care facilities, Iob et al. documented an unadjusted VE of MF59-TIV of 94% (95% CI: 47\u2013100%) [25].",
            "startOffset": 30577,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 28388,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 28153,
                    "startOffset": 28149
                }
            },
            "secId": "s0050",
            "sentence": "In the Canadian study [29], which involved a mixed study population of both community and long-term care facility residents, the VE of MF59-TIV in preventing laboratory-confirmed influenza was 35% and 58% on univariable and multivariable analyses, respectively.",
            "startOffset": 28127,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 28102,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "The characteristics of the studies included are reported in Table 1.",
            "startOffset": 28034,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 19384,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 19144,
                    "startOffset": 19140
                }
            },
            "secId": "s0005",
            "sentence": "The latter finding was later confirmed by an integrated analysis of safety outcomes [10], in which subjects vaccinated with MF59-TIV showed a higher risk than those vaccinated with non-adjuvanted TIV [weighted risk ratio 1.34 (95% CI: 1.28\u20131.40)] in terms of solicited local and systemic reactions within 3 days of immunization.",
            "startOffset": 19056,
            "title": "Introduction"
        },
        {
            "endOffset": 19612,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 19441,
                    "startOffset": 19437
                }
            },
            "secId": "s0005",
            "sentence": "A more recent systematic review by Camilloni et al. [11] suggested that the immunogenicity of MF59-TIV was high in the elderly, and in most instances satisfied the Committee for Medicinal Products for Human Use (CHMP) criteria.",
            "startOffset": 19385,
            "title": "Introduction"
        },
        {
            "endOffset": 25596,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The meta-analysis of ORs (vaccinated with MF59-TIV vs non-vaccinated) was carried out in order to obtain pooled estimates of VE.",
            "startOffset": 25468,
            "title": "Data analysis"
        },
        {
            "endOffset": 29256,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 29199,
                    "startOffset": 29195
                },
                "b0130": {
                    "endOffset": 29056,
                    "startOffset": 29043
                },
                "b0150": {
                    "endOffset": 29211,
                    "startOffset": 29207
                },
                "b0160": {
                    "endOffset": 29056,
                    "startOffset": 29043
                }
            },
            "secId": "s0050",
            "sentence": "Among four case-control community-based studies [24,26,30,32], unadjusted VE in preventing hospitalization for pneumonia and influenza ranged from 9% [24] to 95.2% [30]; this range narrowed (from 48% [24] to 88% [30]) when considering the adjusted VE (Table 2).",
            "startOffset": 28995,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 28942,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "When adjusted estimates were pooled, VE slightly increased to 60.1%; however, although the ES was large, the 95% CI passed through zero (\u22121.3 to 84.3%).",
            "startOffset": 28790,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 32702,
            "parents": [],
            "secId": "s0060",
            "sentence": "Arguably, our meta-analysis included a limited number of papers; Q and I2 statistics may therefore have had a low power.",
            "startOffset": 32582,
            "title": "Discussion"
        },
        {
            "endOffset": 25468,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The relative VE was expressed as an appropriate measure of effect size (OR and RR for case-control and cohort studies, respectively).",
            "startOffset": 25335,
            "title": "Data analysis"
        },
        {
            "endOffset": 26306,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "We planned a priori to conduct a subgroup analysis and/or meta-regression, in order to highlight those study characteristics that were significantly associated with heterogeneity among studies.",
            "startOffset": 26113,
            "title": "Data analysis"
        },
        {
            "endOffset": 17782,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 17781,
                    "startOffset": 17778
                }
            },
            "secId": "s0005",
            "sentence": "However, traditional trivalent inactivated vaccines (TIVs) often induce only a modest immune response in the elderly, owing to immunosenescence [5].",
            "startOffset": 17634,
            "title": "Introduction"
        },
        {
            "endOffset": 37028,
            "parents": [],
            "secId": "s0060",
            "sentence": "In the future, large well-designed observational (especially cohort) studies will undoubtedly help to establish more precise point estimates.",
            "startOffset": 36887,
            "title": "Discussion"
        },
        {
            "endOffset": 30903,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 30902,
                    "startOffset": 30892
                },
                "b0140": {
                    "endOffset": 30902,
                    "startOffset": 30892
                },
                "b0145": {
                    "endOffset": 30902,
                    "startOffset": 30892
                },
                "b0150": {
                    "endOffset": 30902,
                    "startOffset": 30892
                },
                "b0155": {
                    "endOffset": 30902,
                    "startOffset": 30892
                }
            },
            "secId": "s0055",
            "sentence": "Table 4 reports ESs of the comparative VE of MF59-TIV versus other adjuvanted and non-adjuvanted vaccines [25,28\u201331].",
            "startOffset": 30786,
            "title": "Relative effectiveness of MF59-TIV"
        },
        {
            "endOffset": 33478,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, in that study, the reported ES had not been adjusted.",
            "startOffset": 33416,
            "title": "Discussion"
        },
        {
            "endOffset": 34159,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 34158,
                    "startOffset": 34151
                },
                "b0175": {
                    "endOffset": 34158,
                    "startOffset": 34151
                }
            },
            "secId": "s0060",
            "sentence": "On the other hand, both estimates from the studies included and our pooled results were higher than those of other meta-analyses [14,35].",
            "startOffset": 34022,
            "title": "Discussion"
        },
        {
            "endOffset": 21530,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 21529,
                    "startOffset": 21522
                },
                "b0080": {
                    "endOffset": 21529,
                    "startOffset": 21522
                },
                "b0085": {
                    "endOffset": 21529,
                    "startOffset": 21522
                }
            },
            "secId": "s0015",
            "sentence": "Influenza-related outcomes included: laboratory-confirmed influenza [through real-time polymerase chain reaction (RT-PCR) or culture], influenza-like illness (ILI), outpatient visits for influenza and pneumonia, hospitalizations for all respiratory pathologies, for influenza and pneumonia, for cardio- and cerebrovascular accidents, and mortality following hospitalization for influenza and pneumonia [15\u201317].",
            "startOffset": 21120,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 24897,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Any between-rater disagreement was settled by consensus.",
            "startOffset": 24841,
            "title": "Quality assessment of included studies"
        },
        {
            "endOffset": 25111,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 25110,
                    "startOffset": 25106
                }
            },
            "secId": "s0030",
            "sentence": "Studies were categorized as being at low (\u2a7d1 inadequate item on the NOS), medium (2\u20133 inadequate items on the NOS), high (>3 inadequate items on the NOS) or very high (no description of methods) risk of bias [17].",
            "startOffset": 24898,
            "title": "Quality assessment of included studies"
        },
        {
            "endOffset": 25915,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Unadjusted and adjusted effect sizes (ESs) were pooled separately.",
            "startOffset": 25849,
            "title": "Data analysis"
        },
        {
            "endOffset": 24570,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "During the process of study selection and data extraction, any disagreement between the two investigators was settled by consensus and/or consultation of the third investigator (RG).",
            "startOffset": 24388,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 23055,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The following inclusion criteria were applied: (i) use of commercially available formulations of MF59-TIV; (ii) study population aged \u2a7e60/65 years, regardless of setting; (iii) study period determined by influenza or ILI surveillance systems; (iv) case-control or cohort design; (v) studies reporting at least one of the above-mentioned influenza-related outcomes.",
            "startOffset": 22691,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 29826,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "By contrast, no heterogeneity was found (I2 = 0%) when adjusted VEs were meta-analyzed (N = 4 studies), yielding a pooled estimate of 51% (95% CI: 39\u201361%) (Fig. 2B).",
            "startOffset": 29661,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 19055,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 19054,
                    "startOffset": 19051
                }
            },
            "secId": "s0005",
            "sentence": "In that study, MF59-TIV was judged to be well tolerated (most adverse events being mild), although several local and systemic reactions were more common in recipients of the adjuvanted vaccine [9].",
            "startOffset": 18858,
            "title": "Introduction"
        },
        {
            "endOffset": 26112,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "A \u201cleave-one-out\u201d sensitivity analysis was carried out in order to ascertain that the pooled estimates were not driven by single studies.",
            "startOffset": 25975,
            "title": "Data analysis"
        },
        {
            "endOffset": 31742,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 31641,
                    "startOffset": 31637
                }
            },
            "secId": "s0060",
            "sentence": "However, RCTs in this age-class are very uncommon, as ethics committees reject experimental placebo-controlled designs in most jurisdictions [33]; consequently, observational studies are a fundamental way of evaluating influenza VE among seniors.",
            "startOffset": 31496,
            "title": "Discussion"
        },
        {
            "endOffset": 35268,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 35127,
                    "startOffset": 35123
                }
            },
            "secId": "s0060",
            "sentence": "Indeed, a recent systematic review and meta-analysis by Moa et al. [37] reported that immunogenicity elicited by QIV was similar to that of TIV for the shared three strains, but superior to the non-TIV B lineage.",
            "startOffset": 35056,
            "title": "Discussion"
        },
        {
            "endOffset": 27886,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 27788,
                    "startOffset": 27778
                },
                "b0140": {
                    "endOffset": 27788,
                    "startOffset": 27778
                },
                "b0145": {
                    "endOffset": 27788,
                    "startOffset": 27778
                },
                "b0150": {
                    "endOffset": 27788,
                    "startOffset": 27778
                },
                "b0155": {
                    "endOffset": 27788,
                    "startOffset": 27778
                }
            },
            "secId": "s0045",
            "sentence": "Five studies [25,28\u201331] compared the effectiveness of MF59-TIV with that of other adjuvanted and non-adjuvanted vaccines.",
            "startOffset": 27765,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 32092,
            "parents": [],
            "secId": "s0060",
            "sentence": "To our knowledge, the present systematic review is the first that has specifically aimed to evaluate and quantify the effectiveness of MF59-TIV in the elderly.",
            "startOffset": 31933,
            "title": "Discussion"
        },
        {
            "endOffset": 25700,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "To this end, a random-effects model using the DerSimonian-Laird weighting method was first implemented.",
            "startOffset": 25597,
            "title": "Data analysis"
        },
        {
            "endOffset": 33270,
            "parents": [],
            "secId": "s0060",
            "sentence": "This observation can probably be attributed to the small sample sizes in both of the studies included.",
            "startOffset": 33168,
            "title": "Discussion"
        },
        {
            "endOffset": 22565,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Once duplicates had been removed, titles and abstracts obtained from the automatic search were independently screened by two investigators (AD and LA).",
            "startOffset": 22414,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 28033,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "All included studies were judged (once consensus had been reached) to be at medium risk of bias, although inter-rater agreement was low (\u03ba = 0.2).",
            "startOffset": 27887,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 27764,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 27616,
                    "startOffset": 27600
                },
                "b0125": {
                    "endOffset": 27678,
                    "startOffset": 27674
                },
                "b0130": {
                    "endOffset": 27763,
                    "startOffset": 27759
                },
                "b0135": {
                    "endOffset": 27668,
                    "startOffset": 27661
                },
                "b0140": {
                    "endOffset": 27616,
                    "startOffset": 27600
                },
                "b0145": {
                    "endOffset": 27668,
                    "startOffset": 27661
                },
                "b0150": {
                    "endOffset": 27616,
                    "startOffset": 27600
                },
                "b0155": {
                    "endOffset": 27616,
                    "startOffset": 27600
                },
                "b0160": {
                    "endOffset": 27616,
                    "startOffset": 27600
                }
            },
            "secId": "s0045",
            "sentence": "Across the selected studies, the most frequent influenza-related outcome was hospitalization for pneumonia and influenza [24,26,28,30\u201332], followed by laboratory-confirmed influenza [27,29], ILI [25], hospitalization for acute coronary syndrome [26] and cerebrovascular accidents [26].",
            "startOffset": 27479,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 25974,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 25973,
                    "startOffset": 25969
                }
            },
            "secId": "s0035",
            "sentence": "Meta-analysis was not performed when I2 was over 85% [22].",
            "startOffset": 25916,
            "title": "Data analysis"
        },
        {
            "endOffset": 21119,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 21118,
                    "startOffset": 21111
                },
                "b0075": {
                    "endOffset": 21118,
                    "startOffset": 21111
                }
            },
            "secId": "s0015",
            "sentence": "The primary endpoint was the absolute VE, which was defined as the proportional reduction in the risk of influenza-related outcomes among vaccinees (in comparison with non-vaccinated subjects), as recorded in observational studies [12,15].",
            "startOffset": 20880,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 31932,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 31931,
                    "startOffset": 31928
                }
            },
            "secId": "s0060",
            "sentence": "Since it was licensed, more than 20 years ago, MF59-TIV has been approved for human use in about 30 countries, and in most of these it is indicated only for immunization of the elderly [6].",
            "startOffset": 31743,
            "title": "Discussion"
        },
        {
            "endOffset": 27207,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 27139,
                    "startOffset": 27126
                },
                "b0125": {
                    "endOffset": 27168,
                    "startOffset": 27155
                },
                "b0130": {
                    "endOffset": 27139,
                    "startOffset": 27126
                },
                "b0135": {
                    "endOffset": 27139,
                    "startOffset": 27126
                },
                "b0140": {
                    "endOffset": 27168,
                    "startOffset": 27155
                },
                "b0145": {
                    "endOffset": 27206,
                    "startOffset": 27202
                },
                "b0150": {
                    "endOffset": 27168,
                    "startOffset": 27155
                },
                "b0155": {
                    "endOffset": 27139,
                    "startOffset": 27126
                },
                "b0160": {
                    "endOffset": 27168,
                    "startOffset": 27155
                }
            },
            "secId": "s0045",
            "sentence": "Six studies were conducted in Spain [24,26,27,31], four in Italy [25,28,30,32], and the remaining one in Canada [29].",
            "startOffset": 27090,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 36606,
            "parents": [],
            "secId": "s0060",
            "sentence": "In keeping with our aims and outcomes, only observational studies, the biases of which are well known, were comprehensively searched.",
            "startOffset": 36473,
            "title": "Discussion"
        },
        {
            "endOffset": 20218,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 20217,
                    "startOffset": 20214
                }
            },
            "secId": "s0005",
            "sentence": "Furthermore, the absolute VE of a seasonal influenza vaccine in the elderly cannot be demonstrated in placebo-controlled studies for ethical reasons, since immunization of this age-class is highly recommended [8].",
            "startOffset": 20005,
            "title": "Introduction"
        },
        {
            "endOffset": 31109,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The relative effectiveness of MF59-TIV tended to be significantly higher in comparison with intramuscular non-adjuvanted vaccines, but not virosomal (no longer commercially available) and intradermal TIVs.",
            "startOffset": 30904,
            "title": "Relative effectiveness of MF59-TIV"
        },
        {
            "endOffset": 37184,
            "parents": [],
            "secId": "s0060",
            "sentence": "At the review level, the paucity of studies included did not allow us to carry out the subgroup analysis and/or meta-regression that were planned a priori.",
            "startOffset": 37029,
            "title": "Discussion"
        },
        {
            "endOffset": 25334,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "VE was deemed statistically significant when its 95% CI did not pass through zero.",
            "startOffset": 25252,
            "title": "Data analysis"
        },
        {
            "endOffset": 35493,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, it should be noted that, since several factors may impact VE (e.g. age, degree of mismatch, previous vaccination status, priming), the additional benefits of QIV could vary substantially among different populations.",
            "startOffset": 35269,
            "title": "Discussion"
        },
        {
            "endOffset": 36472,
            "parents": [],
            "secId": "s0060",
            "sentence": "Like all systematic reviews, the present one suffers from some limitations.",
            "startOffset": 36397,
            "title": "Discussion"
        },
        {
            "endOffset": 30749,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Table 3 summarizes available data on MF59-TIV VE.",
            "startOffset": 30700,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 34569,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 34469,
                    "startOffset": 34466
                }
            },
            "secId": "s0060",
            "sentence": "This finding is consistent with a pooled analysis of 13 immunogenicity RCTs [9], which found significantly higher antibody titers elicited by MF59-TIV than by non-adjuvanted TIVs.",
            "startOffset": 34390,
            "title": "Discussion"
        },
        {
            "endOffset": 22312,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Reference lists of included studies were manually checked by an expert.",
            "startOffset": 22241,
            "title": "Search strategy"
        },
        {
            "endOffset": 22004,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The last automatic search was performed on 26/04/2016.",
            "startOffset": 21950,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 28789,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Pooled analyses of these two studies revealed a significant unadjusted VE of 58.8% (95% CI: 10.7\u201381.0%).",
            "startOffset": 28685,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 35652,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 35651,
                    "startOffset": 35647
                }
            },
            "secId": "s0060",
            "sentence": "Given that children and young adults have relatively higher attack rates of type B virus, these age-classes would probably be major beneficiaries of QIV [38].",
            "startOffset": 35494,
            "title": "Discussion"
        },
        {
            "endOffset": 37814,
            "parents": [],
            "refoffsets": {
                "b0085": {
                    "endOffset": 37660,
                    "startOffset": 37656
                },
                "b0210": {
                    "endOffset": 37760,
                    "startOffset": 37756
                },
                "b0215": {
                    "endOffset": 37813,
                    "startOffset": 37809
                }
            },
            "secId": "s0060",
            "sentence": "Although the NOS has been used in Cochrane reviews on influenza vaccines [17], previous research has found that the scale is difficult to use, has low inter-rater agreement [42] and low agreement between reviewers and authors [43].",
            "startOffset": 37583,
            "title": "Discussion"
        },
        {
            "endOffset": 21729,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 21728,
                    "startOffset": 21724
                }
            },
            "secId": "s0015",
            "sentence": "Our secondary endpoint was the relative VE, which was assessed by comparing influenza-related outcomes in subjects vaccinated with MF59-TIV with those of recipients of other influenza vaccines [18].",
            "startOffset": 21531,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 26896,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Taken together, the 11 studies enrolled 546,015 person-seasons.",
            "startOffset": 26833,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 25251,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "VE was expressed as [1-odds ratio (OR)]\u00b7100% and [1-risk ratio (RR)]\u00b7100% for case-control and cohort studies, respectively.",
            "startOffset": 25127,
            "title": "Data analysis"
        },
        {
            "endOffset": 31495,
            "parents": [],
            "secId": "s0060",
            "sentence": "Therefore, it is important to evaluate the effectiveness of influenza vaccines in this age-class.",
            "startOffset": 31398,
            "title": "Discussion"
        },
        {
            "endOffset": 36268,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 36192,
                    "startOffset": 36188
                },
                "b0200": {
                    "endOffset": 36091,
                    "startOffset": 36087
                }
            },
            "secId": "s0060",
            "sentence": "A subsequent evaluation by Beyer et al. [40], which was based on an umbrella meta-analysis, indicated that the estimates made by Reed et al. [39] might be too optimistic and restricted to very young and unprimed subjects.",
            "startOffset": 36047,
            "title": "Discussion"
        },
        {
            "endOffset": 22376,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The vaccine manufacturer was asked to suggest relevant studies.",
            "startOffset": 22313,
            "title": "Search strategy"
        },
        {
            "endOffset": 17973,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 17972,
                    "startOffset": 17969
                }
            },
            "secId": "s0005",
            "sentence": "Moreover, adjuvanted vaccines may induce a more rapid and broader (i.e. towards heterologous serotypes) immune response [6].",
            "startOffset": 17849,
            "title": "Introduction"
        },
        {
            "endOffset": 20709,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 20708,
                    "startOffset": 20704
                }
            },
            "secId": "s0015",
            "sentence": "Both cut-offs (60 and 65 years) for defining the elderly were acceptable [14].",
            "startOffset": 20631,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 35055,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 35054,
                    "startOffset": 35050
                }
            },
            "secId": "s0060",
            "sentence": "Considering both a frequent B-type mismatch between trivalent vaccines and circulating B lineages and limited heterotypic activity between the two lineages, QIVs are presumed to provide additional benefits [36].",
            "startOffset": 34844,
            "title": "Discussion"
        },
        {
            "endOffset": 32989,
            "parents": [],
            "secId": "s0060",
            "sentence": "With regard to laboratory-confirmed influenza, adjusted estimates of VE were around 60% in both community and mixed populations (communities and long-term care facilities).",
            "startOffset": 32817,
            "title": "Discussion"
        },
        {
            "endOffset": 35907,
            "parents": [],
            "refoffsets": {
                "b0195": {
                    "endOffset": 35679,
                    "startOffset": 35675
                }
            },
            "secId": "s0060",
            "sentence": "Moreover, Reed et al. [39] estimated that, in the United States population, using QIV instead of TIV would, on average, produce only a modest (about 1.4%) reduction in hospitalizations and mortality, although this estimate was highly dependent on season.",
            "startOffset": 35653,
            "title": "Discussion"
        },
        {
            "endOffset": 28543,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 28542,
                    "startOffset": 28538
                }
            },
            "secId": "s0050",
            "sentence": "When a subgroup analysis of community-dwelling subjects was undertaken, VE exceeded 70%: 73% and 72% in unadjusted and adjusted models, respectively [29].",
            "startOffset": 28389,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 38049,
            "parents": [],
            "secId": "s0060",
            "sentence": "To conclude, the available evidence suggests that MF59-TIV is effective in \u201creal world\u201d conditions, especially in preventing hospitalizations for various influenza complications, and is superior to conventional non-adjuvanted vaccines.",
            "startOffset": 37814,
            "title": "Discussion"
        },
        {
            "endOffset": 20004,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 20003,
                    "startOffset": 19999
                }
            },
            "secId": "s0005",
            "sentence": "Although randomized controlled trials (RCTs) in which the primary endpoints are immunogenicity and/or efficacy are advantageous in terms of rigorous control for biases and prospective monitoring of disease attack rates, observational studies are able to estimate in-field vaccine effectiveness (VE), thereby providing additional useful insights into the \u201creal world\u201d impact of a vaccine [12].",
            "startOffset": 19612,
            "title": "Introduction"
        },
        {
            "endOffset": 24248,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The following information was gathered: first author and year of publication, study location, influenza season, study aim, study design, sample size, setting, age of vaccinees, comparator vaccines (if any), influenza-related outcome/s used, unadjusted and adjusted estimates of VE with 95% confidence intervals (CIs), and potential confounders.",
            "startOffset": 23904,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 26943,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0045",
            "sentence": "Of these, 52.3% were vaccinated with MF59-TIV.",
            "startOffset": 26897,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 17633,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 17632,
                    "startOffset": 17629
                }
            },
            "secId": "s0005",
            "sentence": "In this regard, the European Union Council encourages individual countries to reach a vaccination coverage rate of at least 75% in the elderly [4].",
            "startOffset": 17486,
            "title": "Introduction"
        },
        {
            "endOffset": 18373,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 18372,
                    "startOffset": 18369
                }
            },
            "secId": "s0005",
            "sentence": "Its immuno-stimulatory properties have been extensively demonstrated; it activates local immune cells at the injection site, and promotes transition from monocytes to dendritic cells and recruitment of antigen-presenting cells and antigen uptake [7].",
            "startOffset": 18123,
            "title": "Introduction"
        },
        {
            "endOffset": 36046,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 36045,
                    "startOffset": 36042
                }
            },
            "secId": "s0060",
            "sentence": "Such a modest decrease may be partly attributed to the suboptimal efficacy of non-adjuvanted vaccines, especially in some age-classes [8].",
            "startOffset": 35908,
            "title": "Discussion"
        },
        {
            "endOffset": 27478,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 27398,
                    "startOffset": 27394
                }
            },
            "secId": "s0045",
            "sentence": "The Canadian study [29] had a mixed population (56.7% of subjects living in long-term care facilities).",
            "startOffset": 27375,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 18493,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 18492,
                    "startOffset": 18489
                }
            },
            "secId": "s0005",
            "sentence": "Italy was the first country in which a seasonal TIV vaccine adjuvanted with MF59 (MF59-TIV) was licensed (in 1997) [8].",
            "startOffset": 18374,
            "title": "Introduction"
        },
        {
            "endOffset": 20358,
            "parents": [],
            "secId": "s0005",
            "sentence": "The present systematic review aimed to analyze the VE of seasonal MF59-TIV in preventing several influenza-related outcomes in the elderly.",
            "startOffset": 20219,
            "title": "Introduction"
        },
        {
            "endOffset": 31235,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "A meta-analysis was not feasible, owing to the different study designs, settings, comparators and influenza-related outcomes.",
            "startOffset": 31110,
            "title": "Relative effectiveness of MF59-TIV"
        },
        {
            "endOffset": 36397,
            "parents": [],
            "secId": "s0060",
            "sentence": "Future research, including pharmacoeconomic evaluations, should consider these issues in comparing aTIV and non-adjuvanted QIVs.",
            "startOffset": 36269,
            "title": "Discussion"
        },
        {
            "endOffset": 21949,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 21816,
                    "startOffset": 21813
                },
                "b0095": {
                    "endOffset": 21885,
                    "startOffset": 21881
                }
            },
            "secId": "s0015",
            "sentence": "Owing to the fact that MF59-TIV was first authorized for human use in Italy in 1997 [8] and the first clinical trials were conducted in the early 1990s [19], our search was limited to the period starting from 01/01/1990.",
            "startOffset": 21729,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 33768,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 33655,
                    "startOffset": 33651
                }
            },
            "secId": "s0060",
            "sentence": "Our results are in line with the paper by Gross et al. [34], which reported that influenza vaccination was effective in the elderly against some influenza-related outcomes.",
            "startOffset": 33596,
            "title": "Discussion"
        },
        {
            "endOffset": 30082,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Owing to the paucity of studies, neither publication bias or subgroup analyses could be performed.",
            "startOffset": 29984,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 24388,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "If a study reported VE estimates in different periods of the influenza season, only the estimate calculated close to the peak was recorded.",
            "startOffset": 24249,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 32255,
            "parents": [],
            "secId": "s0060",
            "sentence": "Our results show that MF59-TIV is effective against a number of influenza-related outcomes in the elderly living in both communities and long-term care facilities.",
            "startOffset": 32092,
            "title": "Discussion"
        },
        {
            "endOffset": 38405,
            "parents": [],
            "secId": "s0060",
            "sentence": "In particular, considering that we identified only one study in which the population was composed of institutionalized elderly subjects, future research should target this vulnerable population group.",
            "startOffset": 38205,
            "title": "Discussion"
        },
        {
            "endOffset": 23650,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Exclusion criteria were formulated as follows: (i) non-original research, case reports and similar; (ii) animal studies; (iii) cross-sectional design; (iv) studies of any design aimed to evaluate immunogenicity, vaccine efficacy, tolerability and safety of MF59-TIV; (v) number of subjects vaccinated with MF59-TIV < 50; (vi) influenza diagnosed by means of serology; (vii) studies on subjects with particular chronic conditions (e.g. immunosuppression); (viii) absence of separate data for subjects of different ages (e.g. elderly and non-elderly adults) or vaccinated with different vaccines.",
            "startOffset": 23056,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 29660,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 29537,
                    "startOffset": 29533
                }
            },
            "secId": "s0050",
            "sentence": "The sensitivity analysis (Appendix, Table S2) revealed that, after excluding the study by Gasparini et al. [30], the unadjusted VE dropped to 32.4% (95% CI: \u22127.3 to 57.5%); in any case, heterogeneity was constantly high: at least 70%.",
            "startOffset": 29426,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 18122,
            "parents": [],
            "secId": "s0005",
            "sentence": "The first adjuvant used for seasonal influenza vaccines was the squalene-based adjuvant microfluidized emulsion 59 (MF59), an oil-in-water emulsion.",
            "startOffset": 17974,
            "title": "Introduction"
        },
        {
            "endOffset": 20630,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Observational studies investigating the effectiveness of MF59-TIV in elderly populations were potentially eligible.",
            "startOffset": 20515,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 34021,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 34020,
                    "startOffset": 34016
                }
            },
            "secId": "s0060",
            "sentence": "Specifically, our pooled estimate for hospitalization for pneumonia and influenza was very close to the pooled results of observational studies (53% and 50% in preventing pneumonia and hospitalization, respectively) reported in that meta-analysis [34].",
            "startOffset": 33769,
            "title": "Discussion"
        },
        {
            "endOffset": 34389,
            "parents": [],
            "secId": "s0060",
            "sentence": "Concerning the relative VE, it appears that MF59-TIV is more effective that conventional non-adjuvanted TIVs.",
            "startOffset": 34280,
            "title": "Discussion"
        },
        {
            "endOffset": 36738,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, most of the studies included implemented various measures to minimize biases in selection and information and confounders.",
            "startOffset": 36607,
            "title": "Discussion"
        },
        {
            "endOffset": 30384,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 30166,
                    "startOffset": 30162
                }
            },
            "secId": "s0050",
            "sentence": "Regarding other influenza-related outcomes, in the paper by Puig-Barber\u00e0 et al. [26], MF59-TIV proved to be highly effective in reducing hospitalizations for acute coronary syndrome in the multivariable analysis [VE: 87% (95% CI: 35\u201397%)], but not in the unadjusted one [VE: 11% (95% CI: \u2212108 to 63%)].",
            "startOffset": 30082,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 27374,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 27285,
                    "startOffset": 27269
                },
                "b0125": {
                    "endOffset": 27315,
                    "startOffset": 27311
                },
                "b0130": {
                    "endOffset": 27285,
                    "startOffset": 27269
                },
                "b0135": {
                    "endOffset": 27285,
                    "startOffset": 27269
                },
                "b0140": {
                    "endOffset": 27285,
                    "startOffset": 27269
                },
                "b0150": {
                    "endOffset": 27285,
                    "startOffset": 27269
                },
                "b0155": {
                    "endOffset": 27285,
                    "startOffset": 27269
                },
                "b0160": {
                    "endOffset": 27285,
                    "startOffset": 27269
                }
            },
            "secId": "s0045",
            "sentence": "Most studies (N = 9) were conducted in the community setting [24,26\u201328,30\u201332]; the study by Iob et al. [25] was the only one carried out in long-term care facilities.",
            "startOffset": 27208,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 37582,
            "parents": [],
            "refoffsets": {
                "b0205": {
                    "endOffset": 37581,
                    "startOffset": 37577
                }
            },
            "secId": "s0060",
            "sentence": "Finally, the inter-rater agreement in evaluating the methodological quality of the studies included may be interpreted only as poor to slight [41].",
            "startOffset": 37435,
            "title": "Discussion"
        },
        {
            "endOffset": 18857,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 18616,
                    "startOffset": 18613
                }
            },
            "secId": "s0005",
            "sentence": "The early paper by Podda [9] reported that, compared with non-adjuvanted TIVs, MF59-TIV induced significantly higher levels of immunogenicity in terms of geometrical mean ratios, and seroconversion and seroprotection rates for both primary and subsequent immunizations.",
            "startOffset": 18588,
            "title": "Introduction"
        },
        {
            "endOffset": 37365,
            "parents": [],
            "secId": "s0060",
            "sentence": "For instance, it would have been useful to carry out a subgroup analysis by degree of matching between the strains included in vaccines and those circulating during single seasons.",
            "startOffset": 37185,
            "title": "Discussion"
        },
        {
            "endOffset": 26416,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Assessment of publication bias through Doi plot and LFK index was also planned, but could not be carried out.",
            "startOffset": 26307,
            "title": "Data analysis"
        },
        {
            "endOffset": 24715,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 24648,
                    "startOffset": 24644
                }
            },
            "secId": "s0030",
            "sentence": "The Newcastle-Ottawa scale (NOS) [21] was used to assess the quality of case-control and cohort studies.",
            "startOffset": 24611,
            "title": "Quality assessment of included studies"
        },
        {
            "endOffset": 38204,
            "parents": [],
            "secId": "s0060",
            "sentence": "In our opinion, well-designed and sufficiently powered future observational studies should investigate MF59-TIV VE against laboratory-confirmed influenza.",
            "startOffset": 38050,
            "title": "Discussion"
        },
        {
            "endOffset": 22155,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A comprehensive search was performed in MEDLINE via OVID, Web of Science and Cochrane Library.",
            "startOffset": 22061,
            "title": "Search strategy"
        },
        {
            "endOffset": 27089,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 26987,
                    "startOffset": 26974
                },
                "b0125": {
                    "endOffset": 27017,
                    "startOffset": 27007
                },
                "b0130": {
                    "endOffset": 26987,
                    "startOffset": 26974
                },
                "b0135": {
                    "endOffset": 27088,
                    "startOffset": 27081
                },
                "b0140": {
                    "endOffset": 27017,
                    "startOffset": 27007
                },
                "b0145": {
                    "endOffset": 27088,
                    "startOffset": 27081
                },
                "b0150": {
                    "endOffset": 26987,
                    "startOffset": 26974
                },
                "b0155": {
                    "endOffset": 27017,
                    "startOffset": 27007
                },
                "b0160": {
                    "endOffset": 26987,
                    "startOffset": 26974
                }
            },
            "secId": "s0045",
            "sentence": "Six studies were case-control [24,26,30,32], three were cohort [25,28,31], and two were prospective community-based case-control studies [27,29].",
            "startOffset": 26944,
            "title": "Characteristics of studies included"
        },
        {
            "endOffset": 38575,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 38574,
                    "startOffset": 38570
                }
            },
            "secId": "s0060",
            "sentence": "Indeed, these subjects are particularly at risk of contracting influenza and developing severe complications, owing to their multiple underlying chronic conditions [44].",
            "startOffset": 38406,
            "title": "Discussion"
        },
        {
            "endOffset": 34843,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 34724,
                    "startOffset": 34720
                }
            },
            "secId": "s0060",
            "sentence": "It should be acknowledged that quadrivalent inactivated vaccines (QIVs) that include both lineages of the type B virus have recently become available [36]; to the best of our knowledge, however, no study comparing MF59-TIV and non-adjuvanted QIVs has been published so far.",
            "startOffset": 34570,
            "title": "Discussion"
        },
        {
            "endOffset": 33167,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, in the case of community-dwelling seniors, the lower confidence of the adjusted VE was \u22121.3% and the 95% CIs were fairly broad, suggesting a low precision of estimates.",
            "startOffset": 32990,
            "title": "Discussion"
        },
        {
            "endOffset": 29983,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The sensitivity analyses (Appendix, Table S2) showed consistently robust results, which signifies that the pooled estimate was not driven by a single study.",
            "startOffset": 29827,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 37434,
            "parents": [],
            "secId": "s0060",
            "sentence": "For the same reason, we were not able to check for publication bias.",
            "startOffset": 37366,
            "title": "Discussion"
        },
        {
            "endOffset": 20880,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Study populations were classified, in accordance with the study settings, as community-dwelling subjects, those institutionalized in long-term care facilities, and mixed.",
            "startOffset": 20710,
            "title": "Eligibility criteria"
        },
        {
            "endOffset": 29425,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Pooling of unadjusted estimates of VE (N = 4 studies) revealed a high level of heterogeneity (I2 = 81%); the random-effects model showed a VE of 42% (95% CI: 0.01\u201367%).",
            "startOffset": 29257,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 30577,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 30576,
                    "startOffset": 30572
                }
            },
            "secId": "s0050",
            "sentence": "A similar pattern has been reported with regard to cerebrovascular accidents: VEs of 93% (95% CI: 52\u201399%) and 44% (95% CI: \u221240 to 69%) for adjusted and unadjusted estimates, respectively [26].",
            "startOffset": 30385,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 22240,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 22200,
                    "startOffset": 22193
                },
                "b0100": {
                    "endOffset": 22200,
                    "startOffset": 22193
                }
            },
            "secId": "s0020",
            "sentence": "The search strategy was adapted from [17,20], and is reported in Appendix, Table S1.",
            "startOffset": 22156,
            "title": "Search strategy"
        },
        {
            "endOffset": 31397,
            "parents": [],
            "secId": "s0060",
            "sentence": "Influenza vaccination is highly recommended in the elderly because these subjects are at high risk of developing severe complications due to influenza.",
            "startOffset": 31246,
            "title": "Discussion"
        },
        {
            "endOffset": 32400,
            "parents": [],
            "secId": "s0060",
            "sentence": "Specifically, the adjusted VE in preventing hospitalizations for pneumonia/influenza and acute coronary and cerebrovascular events exceeded 50%.",
            "startOffset": 32256,
            "title": "Discussion"
        },
        {
            "endOffset": 38648,
            "parents": [],
            "secId": "s0065",
            "sentence": "The authors have no conflicts of interest to declare.",
            "startOffset": 38595,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 34280,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 34232,
                    "startOffset": 34225
                },
                "b0175": {
                    "endOffset": 34232,
                    "startOffset": 34225
                }
            },
            "secId": "s0060",
            "sentence": "This finding is, however, plausible, since both earlier analyses [16,35] mostly included studies on non-adjuvanted TIVs.",
            "startOffset": 34160,
            "title": "Discussion"
        },
        {
            "endOffset": 36886,
            "parents": [],
            "secId": "s0060",
            "sentence": "Moreover, as mentioned above, some of our pooled estimates had large CIs, and therefore a relatively low precision of population-wide effect sizes.",
            "startOffset": 36739,
            "title": "Discussion"
        },
        {
            "endOffset": 17485,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 17484,
                    "startOffset": 17479
                },
                "b0015": {
                    "endOffset": 17484,
                    "startOffset": 17479
                }
            },
            "secId": "s0005",
            "sentence": "Vaccination remains the most effective public health measure to reduce the impact of seasonal influenza [2,3].",
            "startOffset": 17375,
            "title": "Introduction"
        },
        {
            "endOffset": 28684,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 28582,
                    "startOffset": 28578
                }
            },
            "secId": "s0050",
            "sentence": "By contrast, in one Spanish study [27], the VE of MF59-TIV in preventing laboratory-confirmed influenza did not reach an \u03b1 < 0.05 (Table 2).",
            "startOffset": 28544,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 28995,
            "parents": [
                {
                    "id": "s0040",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "No heterogeneity was found (both I2 = 0%) (Fig. 2A).",
            "startOffset": 28943,
            "title": "MF59-TIV effectiveness"
        },
        {
            "endOffset": 23903,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Data from selected studies were extracted by two reviewers (AD and LA), each working independently, and were inserted into an ad hoc database.",
            "startOffset": 23761,
            "title": "Study selection and data extraction"
        },
        {
            "endOffset": 32581,
            "parents": [],
            "secId": "s0060",
            "sentence": "Our pooled analysis revealed no heterogeneity among the studies included, suggesting that the vaccination effects were consistent in the four studies that evaluated these outcomes.",
            "startOffset": 32401,
            "title": "Discussion"
        },
        {
            "endOffset": 17374,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17373,
                    "startOffset": 17370
                }
            },
            "secId": "s0005",
            "sentence": "The elderly are particularly vulnerable to seasonal influenza; indeed, approximately 90% of all influenza-related deaths occur among senior citizens [1].",
            "startOffset": 17221,
            "title": "Introduction"
        },
        {
            "endOffset": 24840,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Evaluation was carried out independently by two authors, and the inter-rater agreement was quantified by means of Cohen\u2019s \u03ba.",
            "startOffset": 24716,
            "title": "Quality assessment of included studies"
        },
        {
            "endOffset": 18587,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 18586,
                    "startOffset": 18580
                },
                "b0050": {
                    "endOffset": 18586,
                    "startOffset": 18580
                },
                "b0055": {
                    "endOffset": 18586,
                    "startOffset": 18580
                }
            },
            "secId": "s0005",
            "sentence": "The immunogenicity and safety of MF59-TIV have been studied in several pooled analyses [9\u201311].",
            "startOffset": 18493,
            "title": "Introduction"
        }
    ],
    "docId": "S0264410X1631218X",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Alexander",
                "initial": "A.",
                "last": "Domnich"
            },
            {
                "email": null,
                "first": "Lucia",
                "initial": "L.",
                "last": "Arata"
            },
            {
                "email": null,
                "first": "Daniela",
                "initial": "D.",
                "last": "Amicizia"
            },
            {
                "email": null,
                "first": "Joan",
                "initial": "J.",
                "last": "Puig-Barber\u00e0"
            },
            {
                "email": null,
                "first": "Roberto",
                "initial": "R.",
                "last": "Gasparini"
            },
            {
                "email": "panatto@unige.it",
                "first": "Donatella",
                "initial": "D.",
                "last": "Panatto"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.12.011",
        "firstpage": "513",
        "issn": "0264410X",
        "keywords": [
            "Elderly",
            "Influenza vaccine",
            "Influenza vaccine effectiveness",
            "MF59-adjuvanted vaccine",
            "Meta-analysis"
        ],
        "lastpage": "520",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis"
    }
}